Rubric Capital Management (New York)’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$17.3M Buy
2025
Q1
$9.12M Buy
2024
Q4
$5.14M Buy
2024
Q3
$139K Buy